NCT04406194View on ClinicalTrials.gov

Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 14, 2020

Primary Completion Date

May 22, 2020

Study Completion Date

June 19, 2020

Conditions
Bioequivalence
Interventions
DRUG

FAVICOVIR 200 mg Film Tablet

FAVICOVIR 200 MG FT is containing 200 mg favipiravir manufactured by Atabay, Turkey.

DRUG

AVIGAN 200 mg Film Tablets

AVIGAN 200 mg FT is containing 200 mg favipiravir manufactured by Toyama, Japan.

Trial Locations (2)

27000

Farmagen Ar-Ge Biyot. Ltd. Sti., Şahinbey

06970

Novagenix Drug R&D Center, Akyurt

All Listed Sponsors
collaborator

Novagenix Bioanalytical Drug R&D Center

NETWORK

collaborator

Farmagen Ar-Ge Biyot. Ltd. Sti

NETWORK

lead

Atabay Kimya Sanayi Ticaret A.S.

INDUSTRY

NCT04406194 - Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions | Biotech Hunter | Biotech Hunter